Publicacións en colaboración con investigadores/as de Universidad de Castilla-La Mancha (4)

2014

  1. Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b

    Neurobiology of Disease, Vol. 69, pp. 206-214

  2. Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia

    Journal of Psychiatric Research, Vol. 51, Núm. 1, pp. 49-59

2013

  1. C-terminal-PEDF reduces IC50 doses and chemoresistant population of CD133 and BCRP1-positve cancer stem like cells

    Journal of Analytical Oncology, Vol. 2, Núm. 4, pp. 195-208

  2. Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease

    NeuroMolecular Medicine, Vol. 15, Núm. 2, pp. 295-309